Vaishali Pharma Limited is showing consistent agility and innovation by meeting the needs of its customers in both Domestic and International markets.

The company has built a robust pipeline of around 250 Dossiers. The company's synergistic collaboration with WHO-GMP manufacturing facilities is backed by an excellent rapport with clients.

The company has received the order worth US$73.85 million with an overseas buyer for purchase of Antibiotics Pharmaceutical products. This is the result of correspondence with them since last 6 months.

This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months. As per company's policy, we have done the Due diligence and respective contracts with the overseas Company. We have discussed various prospects with the company for the long-term relations and also we look forward to achieve more orders from them.

"Quality being the primary goal of our association, is the Strength of our Partnership. We have strong foothold in sourcing various products in India. Wherein Vaishali Pharma, is a 30 years old pharmaceutical organization, entirely involved in International Business Marketing of Pharmaceutical Products; along with Nutraceutical Products for Domestic and International Market. Vaishali Pharma holds altogether 250+ Brands in Finished Formulations, Registered in International Market. Our International associations are entirely backed by the Quality Norms we adhere for All Our Products. This will help Company to achieve milestone and reach to new heights.

Vaishali Pharma Limited fastest-growing and most versatile companies in the industry. It has a strong presence in both the domestic and export markets and is currently a supplier to all leading Indian and multinational pharmaceutical companies. The company has been catering to semi-regulated and nonregulated markets across the globe.